More like back then the share register had not been diluted by multiple capital raisings, and there was a lot of hope around the NNZ2256 precursor glypromate which subsequently failed. Beware of attributing stupidity to people in the past - if you brush off their failings as stupidity/naivety or the like, you risk falling into the same trap.
The Case for Yes, page-41
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.12 |
Change
-0.025(0.17%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $15.30 | $14.96 | $4.493M | 296.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 466 | $15.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.12 | 662 | 15 |
View Market Depth
| Last trade - 15.32pm 01/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |